International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Compounding for Veterinary Patients: Pharmaceutical, Biopharmaceutical, Pharmacokinetic and Physiologic Considerations

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 1997 - Compounding for Animals
View All Articles in Issue

Page(s): 233-234

Compounding for Veterinary Patients: Pharmaceutical, Biopharmaceutical, Pharmacokinetic and Physiologic Considerations Page 1

Compounding for Veterinary Patients: Pharmaceutical, Biopharmaceutical, Pharmacokinetic and Physiologic Considerations Page 2

Download in electronic PDF format for $75

Abstract: This article discusses the factors that influence drug concentration in animals, including absorption, distribution, metabolism and excretion. Tables provide information regarding body composition of various animals, including humans; half-lives in hours of selected drugs in animals; drug dosage variations of different animals for two different drugs administered by the intramuscular and intravenous routes and pharmacokinetic parameters of diazepam in the human, dog and rat.

Related Keywords: Animals

Related Categories: VETERINARY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Veterinary Transdermal Medications: A to Z Davidson Gigi S	Mar/Apr 2003 Pg. 106-113
Compounding for Veterinary Patients: Pharmaceutical, Biopharmaceutical, Pharmacokinetic and Physiologic Considerations Allen Loyd V Jr	Jul/Aug 1997 Pg. 233-234
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc	Jan/Feb 2014 Pg. 6-12
Evaluating Transdermals Medication Froms for Veterinary Patients, Part 2 Davidson Gigi S	May/Jun 2001 Pg. 214-215
Navigating New Territories in Compounding for Veterinary Medicine Davidson Gigi S	Sep/Oct 2002 Pg. 324-327
Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy Kochanowska-Karamyan Anna J	Sep/Oct 2016 Pg. 367-374
Providing Positive Outcomes through Compounding for Animal Cancer Patients Davidson Gigi S	Jul/Aug 2000 Pg. 264-272
When to Compound Medications for Veterinary Patients Forsythe Lauren Eichstadt	Jan/Feb 2017 Pg. 19-21
Evaluating Transdermal Medication Forms for Veterinary Patients, Part 1 Davidson Gigi S	Mar/Apr 2001 Pg. 95-96
Single-Patient Trials, Extemporaneously Compounded Products and Pharmaceutical Care Fassett William E	Nov/Dec 2003 Pg. 441-447
Current Topical Treatments in Wound Healing - Part 1 Helmke Christopher D	Jul/Aug 2004 Pg. 269-274
Collecting Laboratory and Other Clinical Efficacy Data on Veterinary Patients Davidson Gigi S, Ashworth Lisa D	Sep/Oct 2002 Pg. 384-385
Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program Okeke Claudia C, Allen Loyd V Jr	Jul/Aug 2010 Pg. 328-331
The Current Landscape of Veterinary Compounding in the Veterinary Setting Gochenauer Alexandria E, Rishniw Mark, Holmes Erin R, Forsythe Lauren R	Sep/Oct 2019 Pg. 428-433
When is Compounding for Animals Legal? Siegner A Wes Jr	May/Jun 1999 Pg. 188-191
The Use of Psychoactive Agents in Veterinary Medicine Simpson Barbara S	Mar/Apr 2001 Pg. 86-88
Drugs Banned for Use in Food Animals: An Explanation Davidson Gigi S	Mar/Apr 2001 Pg. 101-103
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G	Jul/Aug 2015 Pg. 303-305
Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective Timko Robert J, Crooker Philip EM	Mar/Apr 2014 Pg. 101-111
Return to Top